AJANTPHARM
₹2485.7-25 (-1%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Net sales increased to ₹1170.41 Crore in 202503, signaling a solid revenue growth trajectory.
- Operating margin improved in the latest quarter, reaching 21.47%, indicating better cost management.
- Net profit of ₹225.26 Crore showcases robust profitability despite rising expenditures.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,105.15 | 1,054.08 | 1,144.92 | 1,186.64 | 1,146.13 | 1,170.41 | 1,302.65 | 1,353.73 | |
| Expenses | 827.83 | 811.54 | 849.27 | 915.88 | 869.18 | 919.11 | 997.85 | 1,072.26 | |
| Operating Profit | 277.32 | 242.54 | 295.65 | 270.76 | 276.95 | 251.30 | 304.80 | 281.47 | |
| Other Income | 13.59 | 35.50 | 26.47 | 19.48 | 30.44 | 18.11 | 26.33 | 59.34 | |
| Interest | 2.49 | 1.53 | 0.73 | 6.02 | 7.91 | 6.07 | 5.26 | 3.39 | |
| Depreciation | 34.26 | 34.25 | 33.97 | 34.39 | 35.97 | 39.78 | 41.29 | 42.97 | |
| Profit Before Tax | 290.91 | 278.04 | 322.12 | 290.24 | 307.39 | 269.41 | 331.13 | 340.81 | |
| Tax | 80.88 | 75.32 | 76.35 | 73.76 | 74.51 | 44.15 | 75.79 | 80.62 | |
| Net Profit | 210.03 | 202.72 | 245.77 | 216.48 | 232.88 | 225.26 | 255.34 | 260.19 | |
| EPS in Rs | 16.68 | 16.10 | 19.54 | 17.27 | 18.60 | 18 | 20.44 | 20.83 |